Results 331 to 340 of about 174,356 (352)

VEGF; BRAF

Science-Business eXchange, 2012
openaire   +1 more source

Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes

Nature, 2019
Eunyoung Park, Shaun Rawson, Kunhua Li
exaly  

BRAF

2008
openaire   +1 more source

BRAF-Mutationen?

Im Focus Onkologie, 2013
openaire   +1 more source

BRAF targeted therapy changes the treatment paradigm in melanoma

Nature Reviews Clinical Oncology, 2011
Antoni Ribas
exaly  

BRAF

2017
openaire   +1 more source

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Lancet, The, 2012
Axel Hauschild, Jean-Jacques Grob, Ralf Gutzmer   +2 more
exaly  

Targeted agents and immunotherapies: optimizing outcomes in melanoma

Nature Reviews Clinical Oncology, 2017
Jason J Luke, Keith T Flaherty, Antoni Ribas   +2 more
exaly  

Paradoxical oncogenesis—the long-term effects of BRAF inhibition in melanoma

Nature Reviews Clinical Oncology, 2013
Jane L Messina, Vernon K Sondak, Keiran S M Smalley   +2 more
exaly  

RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling

Nature Medicine, 2018
Zhan Yao, Yijun Gao, Rona Yaeger
exaly